| __timestamp | Ionis Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 59644696 |
| Thursday, January 1, 2015 | 37173000 | 79541000 |
| Friday, January 1, 2016 | 48616000 | 98015000 |
| Sunday, January 1, 2017 | 108488000 | 103958000 |
| Monday, January 1, 2018 | 244622000 | 103654000 |
| Tuesday, January 1, 2019 | 287000000 | 128951000 |
| Wednesday, January 1, 2020 | 354000000 | 135799000 |
| Friday, January 1, 2021 | 186000000 | 149883000 |
| Saturday, January 1, 2022 | 151000000 | 220206000 |
| Sunday, January 1, 2023 | 232600000 | 265542000 |
| Monday, January 1, 2024 | 267474000 |
In pursuit of knowledge
In the dynamic world of biotechnology, managing costs is crucial for sustaining innovation and growth. Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Ionis Pharmaceuticals saw a staggering increase of over 1,000% in SG&A expenses, peaking in 2020. This reflects their aggressive expansion and investment in administrative capabilities. Meanwhile, Travere Therapeutics experienced a more moderate rise of approximately 345%, with a notable surge in 2023, indicating strategic scaling efforts. These trends highlight the companies' differing approaches to cost management in a competitive industry. As investors and stakeholders analyze these patterns, understanding the balance between expenditure and innovation becomes paramount for predicting future success.
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Alkermes plc vs Travere Therapeutics, Inc. Trends and Insights
HUTCHMED (China) Limited or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.